Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BRCA1 methylation: a significant role in tumour development?

Aurélie Catteau1, Joanna R Morris

  • 1Division of Medical and Molecular Genetics, GKT School of Medicine, 8th Floor Guy's Tower, Guy's Hospital, London SE1 9RT, UK. catteau@cancer.org.uk

Seminars in Cancer Biology
|August 23, 2002
PubMed
Summary

Epigenetic changes, like BRCA1 gene promoter hypermethylation, can silence tumor suppressor genes, contributing to cancer development. This study reviews evidence for BRCA1 hypermethylation and its role in tumorigenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Denaturing SUMO Immunoprecipitation From Mitotic Cells.

Bio-protocol·2026
Same author

HDAC6-dependent deacetylation of SAE2 enhances SUMO1 conjugation for mitotic integrity.

The EMBO journal·2025
Same author

PIN1-SUMO2/3 motif suppresses excessive RNF168 chromatin accumulation and ubiquitin signaling to promote IR resistance.

Nature communications·2025
Same author

SUMO4 promotes SUMO deconjugation required for DNA double-strand-break repair.

Molecular cell·2025
Same author

USP50 suppresses alternative RecQ helicase use and deleterious DNA2 activity during replication.

Nature communications·2024
Same author

Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Cancer develops through accumulated genetic mutations and epigenetic alterations.
  • Epigenetic changes, specifically DNA methylation, can inactivate critical genes like tumor suppressors.
  • BRCA1 is a key tumor suppressor gene involved in maintaining genome integrity and is linked to breast and ovarian cancer susceptibility.

Purpose of the Study:

  • To summarize evidence supporting BRCA1 gene promoter hypermethylation in tumors.
  • To investigate the mechanisms by which hypermethylation leads to BRCA1 silencing.
  • To compare the impact of BRCA1 hypermethylation versus genetic mutations in tumor development.

Main Methods:

  • Literature review of studies reporting BRCA1 hypermethylation in various cancers.

Related Experiment Videos

  • Analysis of molecular mechanisms underlying BRCA1 promoter methylation and gene silencing.
  • Comparative analysis of epigenetic (hypermethylation) and genetic alterations in BRCA1 function.

    • Main Results:

    • Growing evidence indicates BRCA1 gene promoter hypermethylation is a significant epigenetic event in tumorigenesis.
    • Aberrant methylation patterns lead to the silencing of the BRCA1 tumor suppressor gene.
    • BRCA1 hypermethylation represents an alternative pathway to gene inactivation compared to genetic mutations.

    Conclusions:

    • BRCA1 hypermethylation is a crucial epigenetic mechanism contributing to tumor suppressor gene silencing and potentially cancer initiation/progression.
    • Understanding BRCA1 epigenetic alterations provides insights into alternative cancer development pathways.
    • Epigenetic silencing of BRCA1 may be as significant as genetic mutations in the context of breast and ovarian cancer.